Copyright
©The Author(s) 2023.
World J Hepatol. Feb 27, 2023; 15(2): 237-254
Published online Feb 27, 2023. doi: 10.4254/wjh.v15.i2.237
Published online Feb 27, 2023. doi: 10.4254/wjh.v15.i2.237
Table 7 Univariate and multivariate Cox regression analysis of cirrhosis after propensity score matching
Parameters | Univariate | P value | Multivariate | P value |
HR (95%CI) | HR (95%CI) | |||
Age (yr) | 1.06 (1.01-1.11) | 0.02 | 1.05 (0.99-1.11) | 0.11 |
Hypertension | 3.26 (0.89-11.90) | 0.07 | 0.59 (0.12-2.97) | 0.52 |
Diabetes | 6.74 (0.77-58.81) | 0.08 | 12.21 (1.1-134.4) | 0.04 |
Lobular inflammation | 2.63 (1.02-6.82) | 0.046 | 1.20 (0.26-5.57) | 0.82 |
Ballooning degeneration | 4.33 (1.01-5.15) | 0.006 | 1.80 (0.86-4.48) | 0.02 |
Portal tract inflammation | 2.37 (1.18-4.75) | 0.02 | 72.61 (2.16-2436) | 0.48 |
Fibrosis | 1.57 (0.96-2.56) | 0.07 | 1.03 (0.48-2.25) | 0.93 |
ALT(U/L) | 1.00 (1.00-1.01) | 0.06 | 1.00 (0.99-1.01) | 0.26 |
PLT (× 109/L) | 0.98 (0.96-0.99) | < 0.001 | 0.98 (0.96-0.99) | 0.001 |
- Citation: Tan YW, Wang JM, Zhou XB. Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease. World J Hepatol 2023; 15(2): 237-254
- URL: https://www.wjgnet.com/1948-5182/full/v15/i2/237.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i2.237